Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer

被引:38
作者
Zhang, Li
Zhao, Zhong-Sheng [1 ]
Ru, Guo-Qing
Ma, Jie
机构
[1] Zhejiang Prov Hosp, Dept Pathol, Hangzhou 310014, Zhejiang Provin, Peoples R China
[2] Wenzhou Med Coll, Dept Pathol, Wenzhou 325000, Zhejiang Provin, Peoples R China
[3] Shaoxing Univ Med Coll, Shaoxing 312000, Zhejiang Provin, Peoples R China
关键词
stomach neoplasm; urokinase-type plasminogen activator; urokinase-type plasminogen activator receptor; vascular endothelial growth factor; prognosis;
D O I
10.3748/wjg.v12.i25.3970
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the correlations between the expression of urokinase-type plasminogen activator (uPA) mRNA, uPA receptor (uPAR) mRNA and vascular endothelial growth factor (VEGF) protein and clinicopathologic features, microvessel density (MVD) and survival time. METHODS: In situ hybridization and immuno-histochemistry techniques were used to study the expressions of uPA mRNA, uPAR mRNA, VEGF and CD34 protein in 105 gastric carcinoma specimens. RESULTS: Expressions of uPA mRNA, uPAR mRNA and VEGF protein were observed in 61 (58.1%) cases, 70 (66.7%) cases and 67 (63.8%) cases, respectively. The uPA mRNA and uPAR mRNA positive expression rates in infiltrating-type cases (73.7%, 75.4%), stage III-IV (72.1%, 75.4%), vessel invasion (63.2%, 69.9%), lymphatic metastasis (67.1%, 74.4%) and distant metastasis (88.1%, 85.7%) were significantly higher than those of the expanding-type (chi(2) = 15.57, P = 0.001; chi(2) = 6.91, P = 0.046), stage I-II (chi(2) = 19.22, P = 0.001; chi(2) = 16.75, P = 0.001), non-vessel invasion (chi(2) = 11.92, P = 0.006; chi(2) = 14.15, P = 0.002), nonlymphatic metastasis (chi(2) = 28.41, P = 0.001; chi(2) = 22.5, P = 0.005) and non-distant metastasis (chi(2) = 12.32, P = 0.004; chi(2) = 17.42, P = 0.002; chi(2) = 11.25, P = 0.012; chi(2) = = 18.12, P = 0.002). The VEGF positive expression rates in infiltrating-type cases (75.4%), stage III-IV (88.5%), vessel invasion (82.9%), lymphatic metastasis (84.3%) and distant metastasis (95.2%) were significantly higher than those of the expanding-type (chi(2) = 9.61, P = 0.021), stage I II (chi(2) = 16.66, P = 0.001), non-vessel invasion (chi(2) = 29.38, P = 0.001), non-lymphatic metastasis chi(2) = = 18.68, P = 0.005), and non-distant. metastasis (chi(2) = 22.72, P = 0.007; chi(2) = 21.62, P = 0.004). The mean MVD in the specimens positive for the uPA mRNA, uPAR mRNA and VEGF protein was markedly higher than those with negative expression groups. Moreover, a positive relation between MVD and uPA mRNA (rs = 0.199, P = 0.042), uPAR mRNA (rs = 0.278, P = 0.035), and VEGF (rs = 0.398, P = 0.048) expressions was observed. The mean survival time in cases with positive uPA mRNA, uPAR mRNA and VEGF protein expression or MVD value >= 54.9 was significantly shorter than those in cases with negative expression or MVD value < 54.9. CONCLUSION: uPA and uPAR expressions are correlated with enhanced VEGF-induced tumor angiogenesis and may play a role in invasion and nodal metastasis of gastric carcinoma, thereby serving as prognostic markers of gastric cancer. (C) 2006 The WIG Press. All rights reserved.
引用
收藏
页码:3970 / 3976
页数:7
相关论文
共 32 条
[1]  
Allgayer H, 1998, CLIN EXP METASTAS, V16, P62
[2]   The plasminogen activation system in tumor growth, invasion, and metastasis [J].
Andreasen, PA ;
Egelund, R ;
Petersen, HH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) :25-40
[3]   The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin:: Implications for antiangiogenic strategies [J].
Bajou, K ;
Masson, V ;
Gerard, RD ;
Schmitt, PM ;
Albert, V ;
Praus, M ;
Lund, LR ;
Frandsen, TL ;
Brunner, N ;
Dano, K ;
Fusenig, NE ;
Weidle, U ;
Carmeliet, G ;
Loskutoff, D ;
Collen, D ;
Carmeliet, P ;
Foidart, JM ;
Noël, AS .
JOURNAL OF CELL BIOLOGY, 2001, 152 (04) :777-784
[4]  
Berney CR, 1998, ANTICANCER RES, V18, P973
[5]   Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis [J].
Brodsky, S ;
Chen, J ;
Lee, A ;
Akassoglou, K ;
Norman, J ;
Goligorsky, MS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (04) :H1784-H1792
[6]  
DUFFY MJ, 1990, CANCER RES, V50, P6827
[7]   INDUCTION OF C-FOS GENE-EXPRESSION BY UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN OVARIAN-CANCER CELLS [J].
DUMLER, I ;
PETRI, T ;
SCHLEUNING, WD .
FEBS LETTERS, 1994, 343 (02) :103-106
[8]   INTERACTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) WITH ITS CELLULAR RECEPTOR (U-PAR) INDUCES PHOSPHORYLATION ON TYROSINE OF A 38 KDA PROTEIN [J].
DUMLER, I ;
PETRI, T ;
SCHLEUNING, WD .
FEBS LETTERS, 1993, 322 (01) :37-40
[9]  
ELLIS V, 1991, J BIOL CHEM, V266, P12752
[10]   Role of angiogenesis in tumor growth and metastasis [J].
Folkman, J .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :15-18